We are live on
!
Find out more
CC
Corton Capital Portfolio holdings
AUM
$40.7M
1-Year Est. Return
52.32%
This Fund
S&P 500
This Quarter
Est. Return
+19.06%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$31.4M
(-15%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-29.09%
Top 10 Holdings %
Top 10 Hldgs %
48.99%
Holding
691
New
222
Increased
56
Reduced
93
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$614K |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$592K |
| 3 |
Applied Materials
AMAT
|
+$582K |
| 4 |
Sinclair Inc
SBGI
|
+$529K |
| 5 |
PRA Group
PRAA
|
+$525K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IGMS
IGM Biosciences
IGMS
|
+$1.1M |
| 2 |
Root
ROOT
|
+$981K |
| 3 |
CareDx
CDNA
|
+$929K |
| 4 |
Entrada Therapeutics
TRDA
|
+$924K |
| 5 |
Southern Company
SO
|
+$883K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.81% |
| 2 | Healthcare | 9.35% |
| 3 | Financials | 7.03% |
| 4 | Industrials | 6.34% |
| 5 | Consumer Discretionary | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
301
DELISTED
Walgreens Boots Alliance
WBA
| $152K | 0.09% |
16,266
-56,962
| -78% | -$529K |
|
|
UDMY
302
DELISTED
Udemy
UDMY
| $150K | 0.09% |
+18,245
| New | +$147K |
|
|
STKL
303
DELISTED
SunOpta
STKL
| $150K | 0.09% |
+19,497
| New | +$138K |
|
304
UroGen Pharma
URGN
$2B
| $148K | 0.08% |
13,861
-1,841
| -12% | -$22K |
|
305
Cullinan Oncology
CGEM
$1.08B
| $145K | 0.08% |
+11,944
| New | +$172K |
|
306
Unisys
UIS
$230M
| $143K | 0.08% |
+22,602
| New | +$158K |
|
307
Applied Digital
APLD
$8.05B
| $143K | 0.08% |
+18,674
| New | +$155K |
|
308
Alignment Healthcare
ALHC
$3.85B
| $143K | 0.08% |
12,672
-6,749
| -35% | -$78.9K |
|
309
Luxfer Holdings
LXFR
$455M
| $142K | 0.08% |
+10,885
| New | +$149K |
|
310
Alto Neuroscience
ANRO
$1.11B
| $142K | 0.08% |
+33,553
| New | +$209K |
|
|
SAGE
311
DELISTED
Sage Therapeutics
SAGE
| $141K | 0.08% |
26,025
-2,378
| -8% | -$14.5K |
|
312
Aura Biosciences
AURA
$735M
| $141K | 0.08% |
17,189
-13,230
| -43% | -$125K |
|
313
JetBlue
JBLU
$2.29B
| $140K | 0.08% |
17,803
-40,103
| -69% | -$272K |
|
314
Sotera Health
SHC
$5.09B
| $139K | 0.08% |
+10,195
| New | +$148K |
|
315
Zegna
ZGN
$3.98B
| $139K | 0.08% |
16,785
-2,615
| -13% | -$21.4K |
|
|
AGNT
316
AGNT Inc
AGNT
$641M
| $139K | 0.08% |
+12,039
| New | +$159K |
|
317
Pliant Therapeutics
PLRX
$65.6M
| $138K | 0.08% |
+10,497
| New | +$143K |
|
318
Gogo Inc
GOGO
$559M
| $138K | 0.08% |
17,000
-8,012
| -32% | -$59.7K |
|
|
HBI
319
DELISTED
Hanesbrands
HBI
| $135K | 0.08% |
16,626
+3,151
| +23% | +$24.8K |
|
|
PSTL
320
Postal Realty Trust
PSTL
$694M
| $135K | 0.08% |
10,347
+45
| +0.4% | +$631 |
|
321
American Well
AMWL
$181M
| $134K | 0.08% |
+18,417
| New | +$167K |
|
322
Dana Inc
DAN
$2.91B
| $132K | 0.08% |
+11,419
| New | +$119K |
|
323
LegalZoom.com
LZ
$1.35B
| $132K | 0.08% |
+17,525
| New | +$132K |
|
324
InfuSystem Holdings
INFU
$185M
| $130K | 0.07% |
+15,373
| New | +$121K |
|
|
BRDG
325
DELISTED
Bridge Investment Group
BRDG
| $130K | 0.07% |
15,464
-51,474
| -77% | -$506K |
|
Similar funds
NLVP
BAM
MAM
AM
WCPI
OC
HCM
PI
Corton Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Corton Capital held 691 positions worth $174M, down 15% from $206M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Corton Capital withdrew a net $50.7M in Q4 2024, closing 319 positions and reducing 93 holdings. Its most notable exit was IGM Biosciences, an estimated $1.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Corton Capital opened a new position in Progressive worth $585K.
- Corton Capital's largest Q4 2024 buy was Progressive: 2,441 shares worth $585K.
- Corton Capital added most to United Natural Foods in Q4 2024, an estimated $439K increase.
- Corton Capital's biggest Q4 2024 reduction was Root, cutting an estimated $981K.
- Corton Capital fully exited IGM Biosciences in Q4 2024, selling an estimated $1.1M.
- Corton Capital's ten largest holdings make up 49% of its $174M portfolio in Q4 2024.
- Corton Capital opened 222 new positions and closed 319 in Q4 2024.
- Corton Capital's portfolio value fell 15% quarter-over-quarter to $174M.
Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.